Is the Fda Waiting to Evaluate Madurna's Data?

Vaccines appear to be safe. But how effective are they? That's a great question. Much of the initial data has actually come from looking at the immune response, which is known as amuna bridging. For actual efficacy data, feiser has only announced data on about 17 hundred kids showing an efficacy rate for three doses of about 80 point three%. Madurna reported a lower efficacy rate of 37 to 51 % for its two dose faccine and kids under six.